Headache registration and follow-up program at Tongji Hospital
Official title: Headache Registration and Followup Initiated by Tongji Hospital, HUST
Run by Tongji Hospital · NCT07269561 · Data updated 2026-11-12
This program will collect clinical records, imaging, questionnaires, and blood samples from people aged 6–70 with diagnosed headaches to build a large database to help develop better diagnosis and treatments.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 6 Years to 70 Years |
| Sex | All |
| Enrollment | 50000 (estimated) |
| Sponsor | Tongji Hospital Academic / other |
| Drugs / interventions | immunotherapy |
| Locations | 1 site (Wuhan, Hubei) |
| Status | Recruiting |
| Started | January 1, 2024 |
| Main results expected | December 31, 2028 |
| Study ends | December 31, 2028 |
| Registry record updated | December 8, 2025 |
| Trial ID | NCT07269561 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are people aged 6–70 who meet ICHD-3 headache diagnostic criteria, can give informed consent (or have guardian consent), and can comply with follow-up and questionnaires.
✕Probably not a fit
Patients with highly complex headache etiologies (three or more distinct causes), severe systemic disease with life expectancy under ten years, or major cognitive/psychiatric impairments that prevent follow-up are unlikely to benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a multicenter, prospective observational cohort led by Tongji Hospital that aims to enroll up to 50,000 participants with clinical data and 1,500 participants who provide biological specimens. Initial data collection includes epidemiological information, clinical assessments, imaging, standardized questionnaires, and a 5 ml venous blood sample, with planned multi-omics and biobanking. Participants will be followed for up to 10 years with face-to-face visits in the first three months and annual telephone follow-ups thereafter to record medication use, clinical outcomes, and adverse events. The project will build integrated clinical and multi-omics databases and apply machine-learning and bioinformatics to identify diagnostic markers, drug targets, and precision treatment strategies.
Why it matters
Potential benefit: If successful, this program could lead to more accurate diagnoses, personalized treatment approaches, and identification of new biological targets for people with headaches.
How similar studies have gone: While large population headache cohorts and some biomarker studies exist, combining long-term multi-omics biobanking with machine-learning for precision headache diagnosis and treatment is relatively novel and not yet widely proven.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Meeting the diagnostic criteria for headache classification according to the International Classification of Headache Disorders 3rd edition (ICHD-3, 2018) Age between 6-70 years Voluntary participation with consent Good compliance with follow-up and questionnaire surveys Exclusion Criteria: * Complex headache etiology, e.g., presence of ≥3 distinct factors causing headache Presence of severe systemic diseases or life expectancy less than 10 years Significant cognitive or psychiatric issues that prevent completion of questionnaire follow-ups and clinical assessments
Where it's running
-
Tongji hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China Recruiting
Study contacts
- Study coordinator: Wensheng Qu Professor, DM PhD
- Email: wsqu@tjh.tjmu.edu.cn
- Phone: +8618971622660
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
HEADS Registry: Headache, Ear, Auditory, Dizziness, and Sinus</n> Registry
This registry tests whether collecting online symptom reports from adults in the U.S. with sinus, vestibular, ear, or headache symptoms can help improve diagnosis and treatment.
-
Immediate neck manual therapy effects on atlas position and neck muscles
This trial tests two upper neck manual therapy techniques to see their immediate effect on neck alignment, atlas position, and a neck muscle shape in adults with head and neck pain or headaches.
-
Vitamin IV lidocaine before fundal pressure to prevent headache after cesarean using spinal anesthesia
This trial tests whether a single intravenous dose of lidocaine given before fundal pressure during cesarean delivery reduces the chance or severity of headache.
-
Muscle Position and Dry Needling Efficacy
This study tests whether the position of the upper trapezius during dry needling changes pain and function for people with chronic neck pain.
-
Gentle ear vagus nerve stimulation to reduce headache after aneurysm stent coiling
This study will try a noninvasive ear vagus nerve stimulation device to see if it reduces postoperative headaches in adults having stent-assisted coiling or flow-diverter treatment for unruptured brain aneurysms.
-
Surgical masks versus N95 masks for operating room nurses' symptoms from surgical smoke
This test compares whether surgical masks or N95 masks reduce physical symptoms from surgical smoke in operating room nurses.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.